These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23054950)

  • 1. Pancreatic neuroendocrine tumors.
    Shrikhande SV; Sirohi B; Goel M; Barreto SG
    Indian J Gastroenterol; 2013 Jan; 32(1):3-17. PubMed ID: 23054950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreas neuroendocrine tumors - not so rare or benign.
    Pereira Pérez F
    Rev Esp Enferm Dig; 2016 Nov; 108(11):687-688. PubMed ID: 27756141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Presentation and Diagnosis of Pancreatic Neuroendocrine Tumors.
    Anderson CW; Bennett JJ
    Surg Oncol Clin N Am; 2016 Apr; 25(2):363-74. PubMed ID: 27013370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
    Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies.
    Halfdanarson TR; Strosberg JR
    Curr Clin Pharmacol; 2015; 10(4):305-10. PubMed ID: 26548907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
    Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
    BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology - grading and staging of GEP-NETs.
    Capelli P; Fassan M; Scarpa A
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):705-17. PubMed ID: 23582914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.
    Lam AK; Ishida H
    Histol Histopathol; 2021 Apr; 36(4):367-382. PubMed ID: 33305819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended parameters for pathology reporting of gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
    Malays J Pathol; 2018 Apr; 40(1):79-82. PubMed ID: 29704389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement.
    Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS
    Virchows Arch; 2010 Jun; 456(6):595-7. PubMed ID: 20422210
    [No Abstract]   [Full Text] [Related]  

  • 12. [The new classification of neuroendocrine tumors from the clinical viewpoint].
    Schürmann G; Senninger H
    Z Gastroenterol; 1996 Jun; 34(6):402-3. PubMed ID: 8767831
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
    Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
    Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.
    Klimstra DS; Modlin IR; Coppola D; Lloyd RV; Suster S
    Pancreas; 2010 Aug; 39(6):707-12. PubMed ID: 20664470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
    Oberg K
    Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
    Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
    Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology.
    Scoazec JY; Couvelard A; Leteurtre E; Terris B;
    Ann Endocrinol (Paris); 2013 Jul; 74(3):203-6. PubMed ID: 23768679
    [No Abstract]   [Full Text] [Related]  

  • 18. The changing paradigm of treating pancreatic neuroendocrine tumors.
    Iyer R; Reddy K
    J Natl Compr Canc Netw; 2011 Dec; 9(12):1331-3. PubMed ID: 22157553
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver transplantation for metastatic neuroendocrine tumors.
    Chung H; Chapman WC
    Adv Surg; 2014; 48():235-52. PubMed ID: 25293619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the systemic treatment of pancreatic neuroendocrine tumors.
    Yalcin S
    Cancer Treat Rev; 2011 Apr; 37(2):127-32. PubMed ID: 20705397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.